Clinical Trial Update: A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing valdecoxib 10 mg daily to naproxen 500 mg twice daily for osteoarthritis of the knee or hip; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Naproxen (Naproxen)
• Valdecoxib (valdecoxib)

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED